Trial intelligence / Profile preview

Prophylactic Magnesium Sulfate and Cardiovascular Changes During General Anesthesia in Gynecologic Laparoscopic Surgery

IRCT20190105042236N1Phase 3Completed

Sponsor
Isfahan University of Medical Sciences
Start
Oct 2016
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of magnesium sulfate in Cardiovascular Instability (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Perioperative cardiovascular parameter changes. Started Oct 2016; status: completed.

02

Drugs

magnesium sulfate
03

Conditions

Cardiovascular Instability

Beyond the preview

Go deeper on IRCT20190105042236N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190105042236N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call